GlaxoSmithKline (GSK) reports Q1 results

GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of GBP0.37. Revenue for the quarter came in at GBP6.95 billion.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results